Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,958 | 1,076 | 98.5% |
| Gift | $262.89 | 1 | 1.4% |
| Education | $11.02 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,788 | 123 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,551 | 150 | $0 (2024) |
| Novo Nordisk Inc | $1,887 | 125 | $0 (2024) |
| Lilly USA, LLC | $1,733 | 120 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,239 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,178 | 70 | $0 (2024) |
| PFIZER INC. | $1,091 | 78 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $720.70 | 33 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $600.97 | 40 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $599.00 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,598 | 179 | ABBVIE INC. ($1,037) |
| 2023 | $3,387 | 185 | AbbVie Inc. ($832.24) |
| 2022 | $2,867 | 162 | ABBVIE INC. ($714.64) |
| 2021 | $2,705 | 174 | AstraZeneca Pharmaceuticals LP ($412.39) |
| 2020 | $1,895 | 125 | AstraZeneca Pharmaceuticals LP ($298.38) |
| 2019 | $1,203 | 87 | AstraZeneca Pharmaceuticals LP ($215.49) |
| 2018 | $1,131 | 76 | AstraZeneca Pharmaceuticals LP ($284.70) |
| 2017 | $1,446 | 91 | Tosoh Bioscience, Inc. ($262.89) |
All Payment Transactions
1,079 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), PENBRAYA | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: VACCINES | ||||||
| 12/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Diabetes | ||||||
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Obesity | ||||||
| 12/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.20 | General |
| Category: Cardiovascular | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes Care | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: DIABETES | ||||||
| 11/27/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes Care | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $25.19 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Gastroenterology | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.84 | General |
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 7,543 | 11,564 | $880,193 | $408,738 |
| 2022 | 51 | 8,082 | 12,523 | $926,542 | $426,316 |
| 2021 | 45 | 8,129 | 12,488 | $857,279 | $355,790 |
| 2020 | 43 | 5,786 | 7,732 | $546,882 | $218,963 |
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 691 | 1,339 | $285,207 | $121,994 | 42.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 500 | 500 | $115,500 | $68,689 | 59.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 473 | 665 | $95,760 | $43,697 | 45.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 254 | 254 | $22,860 | $18,126 | 79.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 194 | 194 | $34,920 | $16,307 | 46.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 645 | 1,099 | $41,147 | $14,373 | 34.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 53 | 53 | $15,960 | $14,062 | 88.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 679 | 1,199 | $32,037 | $12,359 | 38.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 737 | 1,427 | $21,405 | $11,862 | 55.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 479 | 661 | $31,027 | $10,880 | 35.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 287 | 287 | $12,657 | $9,436 | 74.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 658 | 1,125 | $25,380 | $8,524 | 33.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 30 | 31 | $14,942 | $6,914 | 46.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 23 | 159 | $21,552 | $6,244 | 29.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 33 | 33 | $10,109 | $5,831 | 57.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 32 | 32 | $8,000 | $5,643 | 70.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 20 | 135 | $18,192 | $5,456 | 30.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 349 | 577 | $15,648 | $5,426 | 34.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 163 | 232 | $9,772 | $3,415 | 35.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $4,485 | $2,257 | 50.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 162 | 238 | $5,998 | $2,095 | 34.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $2,470 | $1,821 | 73.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 83 | 83 | $4,266 | $1,570 | 36.8% |
| 82746 | Folic acid level, serum | Office | 2023 | 81 | 104 | $4,272 | $1,499 | 35.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 33 | 66 | $1,770 | $1,006 | 56.8% |
About Dr. Joena Chan, M.D
Dr. Joena Chan, M.D is a Family Medicine healthcare provider based in Monroe, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760420970.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joena Chan, M.D has received a total of $18,232 in payments from pharmaceutical and medical device companies, with $3,598 received in 2024. These payments were reported across 1,079 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($17,958).
As a Medicare-enrolled provider, Chan has provided services to 29,540 Medicare beneficiaries, totaling 44,307 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Monroe, NY
- Active Since 06/02/2006
- Last Updated 09/27/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760420970
Products in Payments
- FARXIGA (Drug) $1,872
- QULIPTA (Drug) $1,285
- UBRELVY (Drug) $1,119
- ELIQUIS (Drug) $917.35
- TRULICITY (Drug) $754.50
- TRELEGY ELLIPTA (Drug) $656.91
- Ozempic (Drug) $583.63
- TRADJENTA (Drug) $548.50
- XIFAXAN (Drug) $527.26
- JARDIANCE (Drug) $516.68
- VRAYLAR (Drug) $486.58
- Saxenda (Drug) $482.36
- XARELTO (Drug) $472.94
- MOUNJARO (Drug) $372.32
- SHINGRIX (Biological) $359.26
- JANUVIA (Drug) $291.50
- Vascepa (Drug) $278.71
- G8 Elution Buffer No. 1, 800mL (Medical Supply) $262.89
- BREZTRI (Drug) $247.03
- PREVNAR 20 (Biological) $246.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Monroe
Dr. Thomas Dansby, M.d, M.D
Family Medicine — Payments: $227,552
Craig Amnott, D.o, D.O
Family Medicine — Payments: $19,029
Danielle Raley, Md, MD
Family Medicine — Payments: $14,562
Dr. Bonnie Muller, D.o, D.O
Family Medicine — Payments: $11,452
Michelle Plaster, M.d, M.D
Family Medicine — Payments: $10,634
Dr. Kerry Anders, Md, MD
Family Medicine — Payments: $9,566